113 related articles for article (PubMed ID: 24907728)
1. Effects of human amniotic mesenchymal stromal cells on rabbit T-cell responses in a xenolymphocyte reaction assay.
Xue Y; Miao Z; Sun H
Exp Clin Transplant; 2014 Jun; 12(3):253-60. PubMed ID: 24907728
[TBL] [Abstract][Full Text] [Related]
2. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities.
Magatti M; De Munari S; Vertua E; Gibelli L; Wengler GS; Parolini O
Stem Cells; 2008 Jan; 26(1):182-92. PubMed ID: 17901399
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.
Wolbank S; Peterbauer A; Fahrner M; Hennerbichler S; van Griensven M; Stadler G; Redl H; Gabriel C
Tissue Eng; 2007 Jun; 13(6):1173-83. PubMed ID: 17518752
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of Biological Characteristics and Immunosuppressive Activity between Human Amniotic Mesenchymal Stem Cells and Human Bone Marrow Mesenchymal Stem Cells].
Hong JQ; Gao Y; Song J; Zhuo WB; Sun HT; Ping BH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):858-64. PubMed ID: 27342523
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
7. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas.
Bray LJ; Heazlewood CF; Munster DJ; Hutmacher DW; Atkinson K; Harkin DG
Cytotherapy; 2014 Jan; 16(1):64-73. PubMed ID: 24094499
[TBL] [Abstract][Full Text] [Related]
9. [Human amniotic mesenchymal stem cells inhibit allogeneic lymphocyte proliferation and reduce the secretion of interferon γ].
Song J; Cong S; Li Y; Bai L; Cao G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):333-7. PubMed ID: 25744838
[TBL] [Abstract][Full Text] [Related]
10. Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration.
Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
Int Immunopharmacol; 2013 Apr; 15(4):693-702. PubMed ID: 23499510
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of human amniotic mesenchymal stem cells and their chondrogenic differentiation.
Nogami M; Tsuno H; Koike C; Okabe M; Yoshida T; Seki S; Matsui Y; Kimura T; Nikaido T
Transplantation; 2012 Jun; 93(12):1221-8. PubMed ID: 23318305
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment.
Lange-Consiglio A; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
Equine Vet J; 2013 Nov; 45(6):737-44. PubMed ID: 23527626
[TBL] [Abstract][Full Text] [Related]
13. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice.
Deng W; Han Q; Liao L; You S; Deng H; Zhao RC
DNA Cell Biol; 2005 Jul; 24(7):458-63. PubMed ID: 16008514
[TBL] [Abstract][Full Text] [Related]
14. Construction of tissue engineered skin with human amniotic mesenchymal stem cells and human amniotic epithelial cells.
Yu SC; Xu YY; Li Y; Xu B; Sun Q; Li F; Zhang XG
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4627-35. PubMed ID: 26698261
[TBL] [Abstract][Full Text] [Related]
15. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
16. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
17. Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls.
Pianta S; Magatti M; Vertua E; Bonassi Signoroni P; Muradore I; Nuzzo AM; Rolfo A; Silini A; Quaglia F; Todros T; Parolini O
J Cell Mol Med; 2016 Jan; 20(1):157-69. PubMed ID: 26515425
[TBL] [Abstract][Full Text] [Related]
18. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes.
Magatti M; De Munari S; Vertua E; Nassauto C; Albertini A; Wengler GS; Parolini O
Cell Transplant; 2009; 18(8):899-914. PubMed ID: 19523334
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells from Human Amniotic Membrane and Umbilical Cord Can Diminish Immunological Response in an in vitro Allograft Model.
Dabrowski FA; Burdzinska A; Kulesza A; Chlebus M; Kaleta B; Borysowski J; Zolocinska A; Paczek L; Wielgos M
Gynecol Obstet Invest; 2017; 82(3):267-275. PubMed ID: 27627653
[TBL] [Abstract][Full Text] [Related]
20. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
